Kilitch Drugs Financials
| KILITCH Stock | 312.55 5.35 1.68% |
Kilitch |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | India Stock View All |
| Exchange | National Stock Exchange of India |
| ISIN | INE729D01010 |
| Business Address | 3739, Ujagar Industrial |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.kilitch.com |
| Phone | 91 22 6121 4100 |
You should never invest in Kilitch Drugs without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Kilitch Stock, because this is throwing your money away. Analyzing the key information contained in Kilitch Drugs' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Kilitch Drugs Key Financial Ratios
Kilitch Drugs' financial ratios allow both analysts and investors to convert raw data from Kilitch Drugs' financial statements into concise, actionable information that can be used to evaluate the performance of Kilitch Drugs over time and compare it to other companies across industries.| Return On Equity | 0.0832 | ||||
| Return On Asset | 0.0566 | ||||
| Target Price | 466.0 | ||||
| Number Of Employees | 168 | ||||
| Beta | 0.24 |
Kilitch Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Kilitch Drugs's current stock value. Our valuation model uses many indicators to compare Kilitch Drugs value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Kilitch Drugs competition to find correlations between indicators driving Kilitch Drugs's intrinsic value. More Info.Kilitch Drugs Limited is currently regarded as number one stock in return on equity category among its peers. It also is currently regarded as number one stock in return on asset category among its peers reporting about 0.68 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Kilitch Drugs Limited is roughly 1.47 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kilitch Drugs by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kilitch Drugs' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Kilitch Drugs Limited Systematic Risk
Kilitch Drugs' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Kilitch Drugs volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Beta measures systematic risk based on how returns on Kilitch Drugs Limited correlated with the market. If Beta is less than 0 Kilitch Drugs generally moves in the opposite direction as compared to the market. If Kilitch Drugs Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Kilitch Drugs Limited is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Kilitch Drugs is generally in the same direction as the market. If Beta > 1 Kilitch Drugs moves generally in the same direction as, but more than the movement of the benchmark.
Kilitch Drugs Thematic Clasifications
Kilitch Drugs Limited is part of Drugs investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery
This theme covers Drug manufacturing and delivery. Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. Get More Thematic Ideas
| Drugs | View |
Kilitch Drugs February 26, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Kilitch Drugs help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Kilitch Drugs Limited. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kilitch Drugs Limited based on widely used predictive technical indicators. In general, we focus on analyzing Kilitch Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kilitch Drugs's daily price indicators and compare them against related drivers.
| Downside Deviation | 2.02 | |||
| Information Ratio | 0.0135 | |||
| Maximum Drawdown | 10.03 | |||
| Value At Risk | (3.03) | |||
| Potential Upside | 4.47 |
Complementary Tools for Kilitch Stock analysis
When running Kilitch Drugs' price analysis, check to measure Kilitch Drugs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kilitch Drugs is operating at the current time. Most of Kilitch Drugs' value examination focuses on studying past and present price action to predict the probability of Kilitch Drugs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kilitch Drugs' price. Additionally, you may evaluate how the addition of Kilitch Drugs to your portfolios can decrease your overall portfolio volatility.
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |